Teleflex Incorporated (NYSE:TFX) Stake Raised by Natixis Advisors LLC

Natixis Advisors LLC increased its stake in Teleflex Incorporated (NYSE:TFX - Free Report) by 60.6% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 21,160 shares of the medical technology company's stock after buying an additional 7,982 shares during the period. Natixis Advisors LLC's holdings in Teleflex were worth $2,924,000 at the end of the most recent reporting period.

Other institutional investors have also recently added to or reduced their stakes in the company. MassMutual Private Wealth & Trust FSB increased its position in shares of Teleflex by 103.1% in the 1st quarter. MassMutual Private Wealth & Trust FSB now owns 197 shares of the medical technology company's stock worth $27,000 after purchasing an additional 100 shares during the last quarter. Banque Cantonale Vaudoise acquired a new position in Teleflex in the first quarter worth about $27,000. Headlands Technologies LLC bought a new stake in Teleflex in the fourth quarter valued at about $29,000. Whipplewood Advisors LLC increased its holdings in Teleflex by 7,700.0% in the first quarter. Whipplewood Advisors LLC now owns 234 shares of the medical technology company's stock valued at $32,000 after buying an additional 231 shares during the last quarter. Finally, Allworth Financial LP raised its stake in Teleflex by 504.8% during the first quarter. Allworth Financial LP now owns 254 shares of the medical technology company's stock valued at $34,000 after buying an additional 212 shares in the last quarter. 95.62% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In related news, Director Jaewon Ryu purchased 1,500 shares of the company's stock in a transaction on Tuesday, August 5th. The shares were bought at an average cost of $115.00 per share, for a total transaction of $172,500.00. Following the transaction, the director owned 3,727 shares of the company's stock, valued at $428,605. This represents a 67.36% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available through this link. Also, CEO Liam Kelly purchased 1,500 shares of Teleflex stock in a transaction dated Tuesday, August 5th. The stock was bought at an average cost of $115.07 per share, with a total value of $172,605.00. Following the completion of the purchase, the chief executive officer owned 45,267 shares in the company, valued at approximately $5,208,873.69. This trade represents a 3.43% increase in their position. The disclosure for this purchase can be found here. Insiders have purchased 5,500 shares of company stock worth $633,590 over the last ninety days. 1.40% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

A number of brokerages have recently weighed in on TFX. Mizuho boosted their price target on Teleflex from $130.00 to $135.00 and gave the company a "neutral" rating in a report on Friday, August 1st. Royal Bank Of Canada boosted their target price on shares of Teleflex from $130.00 to $135.00 and gave the company a "sector perform" rating in a research note on Friday, August 1st. Wells Fargo & Company reduced their price target on shares of Teleflex from $137.00 to $131.00 and set an "equal weight" rating on the stock in a research report on Friday, August 1st. Morgan Stanley decreased their price target on shares of Teleflex from $191.00 to $173.00 and set an "overweight" rating for the company in a report on Monday, May 5th. Finally, Wall Street Zen raised shares of Teleflex from a "hold" rating to a "strong-buy" rating in a research report on Saturday, August 2nd. One equities research analyst has rated the stock with a sell rating, eight have given a hold rating, one has assigned a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, Teleflex has a consensus rating of "Hold" and a consensus price target of $141.57.

Teleflex Stock Performance

Shares of Teleflex stock traded up $3.08 during trading on Friday, hitting $118.57. 701,177 shares of the stock were exchanged, compared to its average volume of 806,598. The company has a debt-to-equity ratio of 0.42, a quick ratio of 1.44 and a current ratio of 2.41. Teleflex Incorporated has a 12 month low of $108.90 and a 12 month high of $249.90. The stock's fifty day moving average is $118.09 and its 200 day moving average is $134.92. The stock has a market cap of $5.24 billion, a PE ratio of 27.90, a P/E/G ratio of 1.56 and a beta of 1.08.

Teleflex (NYSE:TFX - Get Free Report) last posted its earnings results on Thursday, July 31st. The medical technology company reported $3.73 EPS for the quarter, topping the consensus estimate of $3.36 by $0.37. Teleflex had a net margin of 6.31% and a return on equity of 15.08%. The firm had revenue of $780.90 million during the quarter, compared to analysts' expectations of $771.53 million. During the same quarter in the prior year, the firm earned $3.42 EPS. Teleflex's quarterly revenue was up 4.2% on a year-over-year basis. As a group, sell-side analysts anticipate that Teleflex Incorporated will post 13.98 EPS for the current year.

Teleflex Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Monday, September 15th. Shareholders of record on Friday, August 15th will be paid a dividend of $0.34 per share. The ex-dividend date of this dividend is Friday, August 15th. This represents a $1.36 annualized dividend and a yield of 1.1%. Teleflex's payout ratio is presently 32.00%.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.